NDC 25021-615 – Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride
Dexmedetomidine Hydrochloride 4 ug/mL · Injection, Solution · Intravenous
Product NDC25021-615
Product details
- Brand name
- Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride
- Generic name
- Dexmedetomidine hydrochloride
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA217308
- Marketed since
- February 15, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Active ingredients
- Dexmedetomidine Hydrochloride 4 ug/mL
Uses, dosage, side effects and warnings for Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 25021-615-50 | 10 BOTTLE in 1 CARTON (25021-615-50) / 50 mL in 1 BOTTLE | Feb 15, 2024 |
| 25021-615-51 | 10 BOTTLE in 1 CARTON (25021-615-51) / 100 mL in 1 BOTTLE | Feb 15, 2024 |
Other Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride products
- 43066-555 Dexmedetomidine Hydrochloride 200 ug/50mL · Injection · Baxter Healthcare Company
- 43066-557 Dexmedetomidine Hydrochloride 400 ug/100mL · Injection · Baxter Healthcare Company
- 84549-493 Dexmedetomidine Hydrochloride 4 ug/mL · Injection · ProPharma Distribution
- 0781-3493 Dexmedetomidine Hydrochloride 4 ug/mL · Injection · Sandoz Inc.
- 0781-3494 Dexmedetomidine Hydrochloride 4 ug/mL · Injection · Sandoz Inc.
- 0781-3495 Dexmedetomidine Hydrochloride 4 ug/mL · Injection · Sandoz Inc.